Kalaris Therapeutics Inc

NASDAQ:KLRS

Biotechnology

Healthcare
$2.30 +3.52%

+$0.16 today

Market cap
$54.75M
Beta
0.14
P/E (TTM)
-2.5
EPS (TTM)
-$1.86
52W Low $2.14High $11.88

Volume 0.07M

Average 0.08M

Price history

Kalaris Therapeutics Inc SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-66.67%

Period high

$10.98

Period low

$2.30

Latest

$2.30

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GOct 26, 2026Oct 26, 2026

Competitors

Who does Kalaris Therapeutics Inc compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about KLRS's filings, answered from its disclosures.

What is the latest KLRS filing?

The latest filing shown is SC 13G dated Oct 26, 2026.

How many recent filings does KLRS have?

Intrinsic Alpha currently shows 1 recent filings for KLRS.